<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-pharmaceutics-12-00171">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus</article-title>
  <source>IJN</source>
  <year>2017</year>
  <volume>12</volume>
  <fpage>5733</fpage>
  <lpage>5743</lpage>
  <pub-id pub-id-type="doi">10.2147/IJN.S140939</pub-id>
  <pub-id pub-id-type="pmid">28848350</pub-id>
 </element-citation>
</ref>
